Manufacturing

Perspective

Are You Ready for Serialization Implementation?

Serialization implementation is probably on your radar already if you’re an executive at an emerging Biopharma company. Manufacturers need to…

Perspective

Benefits of Using Foreign Trade Zones for Emerging Biotech Companies

We often see clients incurring high duties on importing key starting materials into the US. For emerging companies conducting R&D,…

Perspective

2022 Industry Serialization Requirements: Assessing 3PL Options for Sending EPCIS Data to Distributors

Pharmaceutical manufacturers currently share transaction data with their trading partners at the lot level. The Drug Supply Chain Security Act…

Perspective

Bottles on a Conveyor Belt

Pushing “Fast Forward” on Serialization Requirements: What Manufacturers Need to Do for 2022

  Per DSCSA, the U.S. pharmaceutical industry must be exchanging EPCIS data at the serialized package level by November 27,…

Perspective

Manufacturers Need to Start Now to Prepare for 2022 Serialization Requirements

While the Drug Supply Chain Security Act (DSCSA) does not require manufacturers to send package-level serialization data downstream until November…

Perspective

Impact of COVID-19 balanced out by federal regulations

Event Recap: Biopharmaceutical Supplier Risk Management – What You Need to Know Now

The COVID-19 pandemic exposed the risks and fragility inherent in global pharmaceutical and biotechnology supply chains. This isn’t really news though. For…

Perspective

Global Trade Compliance: Why Emerging Biopharmaceutical Company Operations Executives Need to Take Notice

Today’s biopharmaceutical supply chains often stretch around the world. Key starting materials (KSM) and API originate more frequently from Asia.…

Perspective

The CARES Act & Your Supply Chain: What You Need to Know

The COVID-19 pandemic and resulting economic crisis exposed the vulnerabilities of both domestic and global supply chains across multiple industries.…

Perspective

U.S. White House

Building Supply Chain Resilience: The Biden Administration’s 100-Day Supply Chain Review Findings on Pharmaceuticals and APIs

On February 24, 2021, President Biden signed an Executive Order on America’s Supply Chains (EO) as a step toward building more secure, robust and resilient…

Perspective

Event Recap: Global Logistics & Trade in a Post-Pandemic World

The current pandemic is severely impacting life science supply chains. There are supply delays, constrained transportation and cold storage, and…

Contact Us

Converge Consulting exclusively serves the Life Sciences industry with strategy, operations, and execution expertise. We are based in the Boston/Cambridge area, one of the most active hubs for Life Sciences best practices in the world.